- Home
- ACIU vs PAMT Comparison
ACIU vs PAMT Comparison
Compare ACIU & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PAMT
- Stock Information
- Founded
- ACIU 2003
- PAMT 1980
- Country
- ACIU Switzerland
- PAMT United States
- Employees
- ACIU N/A
- PAMT N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PAMT Trucking Freight/Courier Services
- Sector
- ACIU Health Care
- PAMT Industrials
- Exchange
- ACIU Nasdaq
- PAMT Nasdaq
- Market Cap
- ACIU 173.7M
- PAMT 301.4M
- IPO Year
- ACIU 2016
- PAMT 1985
- Fundamental
- Price
- ACIU $1.69
- PAMT $16.55
- Analyst Decision
- ACIU Strong Buy
- PAMT Hold
- Analyst Count
- ACIU 2
- PAMT 1
- Target Price
- ACIU $10.00
- PAMT $12.50
- AVG Volume (30 Days)
- ACIU 133.4K
- PAMT 42.1K
- Earning Date
- ACIU 04-30-2025
- PAMT 04-23-2025
- Dividend Yield
- ACIU N/A
- PAMT N/A
- EPS Growth
- ACIU N/A
- PAMT N/A
- EPS
- ACIU N/A
- PAMT N/A
- Revenue
- ACIU $32,014,254.00
- PAMT $687,396,000.00
- Revenue This Year
- ACIU N/A
- PAMT $0.61
- Revenue Next Year
- ACIU $676.94
- PAMT $10.29
- P/E Ratio
- ACIU N/A
- PAMT N/A
- Revenue Growth
- ACIU 91.20
- PAMT N/A
- 52 Week Low
- ACIU $1.43
- PAMT $11.01
- 52 Week High
- ACIU $4.98
- PAMT $23.70
- Technical
- Relative Strength Index (RSI)
- ACIU 46.75
- PAMT N/A
- Support Level
- ACIU $1.55
- PAMT N/A
- Resistance Level
- ACIU $1.79
- PAMT N/A
- Average True Range (ATR)
- ACIU 0.10
- PAMT 0.00
- MACD
- ACIU 0.03
- PAMT 0.00
- Stochastic Oscillator
- ACIU 66.67
- PAMT 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.